{"DataElement":{"publicId":"2748902","version":"1","preferredName":"Systemic Scleroderma Involvement Type","preferredDefinition":"Affecting an entire system._chronic hardening and thickening of the skin caused by swelling and thickening of fibrous tissue leading to eventual atrophy of the epidermis; can occur as a localized or a systemic disease._To have a connection by participation or association or use; sharing in an activity or process._Type; a subdivision of a particular kind of thing.","longName":"SYS_SCD_INV_TYP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2748518","version":"1","preferredName":"Systemic Scleroderma Involvement","preferredDefinition":"Affecting an entire system._chronic hardening and thickening of the skin caused by swelling and thickening of fibrous tissue leading to eventual atrophy of the epidermis; can occur as a localized or a systemic disease._To have a connection by participation or association or use; sharing in an activity or process.","longName":"SYS_SCL_INV","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2716887","version":"1","preferredName":"Systemic Scleroderma","preferredDefinition":"(sis-TEM-ik) Affecting the entire body.:A chronic disorder marked by hardening and thickening of the skin.  Scleroderma can be localized or it can affect the entire body (systemic).","longName":"C13310:C26746","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic","conceptCode":"C13310","definition":"Affecting an entire system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scleroderma","conceptCode":"C26746","definition":"A localized or systemic chronic and progressive autoimmune disorder characterized by thickening of the skin and the connective tissues. Localized scleroderma affects only the skin. Systemic scleroderma affects internal organs, including the heart, lungs, gastrointestinal tract, and kidneys.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41D279CA-C0D4-26A5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-12-21","modifiedBy":"ONEDATA","dateModified":"2007-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CBAF93D-0846-42BA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-08","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2748804","version":"1","preferredName":"Systemic Scleroderma Involvement Type","preferredDefinition":"Affecting an entire system._chronic hardening and thickening of the skin caused by swelling and thickening of fibrous tissue leading to eventual atrophy of the epidermis; can occur as a localized or a systemic disease._To have a connection by participation or association or use; sharing in an activity or process._Type; a subdivision of a particular kind of thing.","longName":"SYS_SCL_INV_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"22","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Raynaud","valueDescription":"Raynaud's Syndrome","ValueMeaning":{"publicId":"2749580","version":"1","preferredName":"Raynaud's Syndrome","longName":"2749580","preferredDefinition":"A set of symptoms characteristic of peripheral vascular disease, namely caused by an inappropriate response of the peripheral arteries in reaction to environmental stimuli, usually to the cold. The term is used when an underlying disease (mostly connective tissue/autoimmune disorders such as lupus, scleroderma, rheumatoid arthritis, etc.) is primarily causative and a range of symptoms including the peripheral vascular spasm is secondary. The term does not refer to the primary Raynauds or Raynauds disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Raynaud Phenomenon","conceptCode":"C50724","definition":"An episodic vasoconstriction resulting in discoloration of the skin and pain in the affected areas, often involving fingers or toes. Classically associated with triphasic color changes (white, blue, red) but may be biphasic. Often occurs in response to cold temperatures or emotional stress. May be primary or secondary to an underlying autoimmune disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D22ACD9-297D-4DC9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D22ACD9-2996-4DC9-E044-0003BA3F9857","beginDate":"2008-05-13","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-13","modifiedBy":"CZECHS","dateModified":"2008-05-13","deletedIndicator":"No"},{"value":"CREST","valueDescription":"CREST Syndrome","ValueMeaning":{"publicId":"2749581","version":"1","preferredName":"CREST Syndrome","longName":"2749581","preferredDefinition":"A variant of systemic sclerosis characterized by calcinosis, Raynaud phenomenon, esophageal motility disorders, sclerodactyly, and telangiectasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CREST Syndrome","conceptCode":"C70646","definition":"A variant of systemic sclerosis characterized by calcinosis, Raynaud phenomenon, esophageal motility disorders, sclerodactyly, and telangiectasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D22ACD9-29A4-4DC9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D22ACD9-29BD-4DC9-E044-0003BA3F9857","beginDate":"2008-05-13","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-13","modifiedBy":"CZECHS","dateModified":"2008-05-13","deletedIndicator":"No"},{"value":"Diffuse cutaneous","valueDescription":"Diffuse Cutaneous","ValueMeaning":{"publicId":"2748805","version":"1","preferredName":"Diffuse Cutaneous","longName":"2748805","preferredDefinition":"widely spread; not localized or confined.: (kyoo-TAY-nee-us) Having to do with the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cutaneous","conceptCode":"C13316","definition":"Involving the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0C70EA-451E-52CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C463-0C36-E044-0003BA3F9857","beginDate":"2008-05-12","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Esophagus","valueDescription":"Esophagus","ValueMeaning":{"publicId":"2567240","version":"1","preferredName":"Esophagus","longName":"2567240","preferredDefinition":"The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagus","conceptCode":"C12389","definition":"The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3B5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CZECHS","dateModified":"2008-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C46F-0C36-E044-0003BA3F9857","beginDate":"2008-05-13","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Limited cutaneous","valueDescription":"Local Cutaneous","ValueMeaning":{"publicId":"2748806","version":"1","preferredName":"Local Cutaneous","longName":"2748806","preferredDefinition":"Of or belonging to a restricted area or locality.: (kyoo-TAY-nee-us) Having to do with the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cutaneous","conceptCode":"C13316","definition":"Involving the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0C70EA-4546-52CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C484-0C36-E044-0003BA3F9857","beginDate":"2008-05-12","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Lung parenchyma","valueDescription":"Lung Tissue","ValueMeaning":{"publicId":"2748807","version":"1","preferredName":"Lung Tissue","longName":"2748807","preferredDefinition":"Tissue consisting of an external serous coat, subserous areolar tissue and lung parenchyma. The parenchyma is made up of lobules wound together by connective tissue. A primary lobule consists of a terminal bronchiole, respiratory bronchioles, and alveolar ducts, which communicate with many alveoli, each alveolus being surrounded by a network of capillary blood vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Tissue","conceptCode":"C33024","definition":"Tissue consisting of an external serous coat, subserous areolar tissue and lung parenchyma. The parenchyma is made up of lobules wound together by connective tissue. A primary lobule consists of a terminal bronchiole, respiratory bronchioles, and alveolar ducts, which communicate with many alveoli, each alveolus being surrounded by a network of capillary blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0C70EA-456D-52CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C499-0C36-E044-0003BA3F9857","beginDate":"2008-05-12","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C4A5-0C36-E044-0003BA3F9857","beginDate":"2008-05-13","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Pulmonary hypertension","valueDescription":"Pulmonary Hypertension","ValueMeaning":{"publicId":"2748808","version":"1","preferredName":"Pulmonary Hypertension","longName":"2748808","preferredDefinition":"increased pressure with the the pulmonary circulation, usually secondary to cardiac or pulmonary disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Hypertension","conceptCode":"C3120","definition":"Increased pressure within the pulmonary circulation due to lung or heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0C70EA-4592-52CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C4CF-0C36-E044-0003BA3F9857","beginDate":"2008-05-12","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Renal","valueDescription":"Renal","ValueMeaning":{"publicId":"2567551","version":"1","preferredName":"Renal","longName":"2567551","preferredDefinition":"Of or pertaining to the kidney.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"CZECHS","dateModified":"2008-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C4DB-0C36-E044-0003BA3F9857","beginDate":"2008-05-13","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Systemic hypertension","valueDescription":"Hypertension Systemic","ValueMeaning":{"publicId":"2749578","version":"1","preferredName":"Hypertension Systemic","longName":"2749578","preferredDefinition":"Abnormally high blood pressure.: (sis-TEM-ik) Affecting the entire body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Systemic","conceptCode":"C13310","definition":"Affecting an entire system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D22ACD9-290C-4DC9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D483A98-C4F0-0C36-E044-0003BA3F9857","beginDate":"2008-05-13","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Other GI tract","valueDescription":"Other Gastrointestinal Tract","ValueMeaning":{"publicId":"2751470","version":"1","preferredName":"Other Gastrointestinal Tract","longName":"2751470","preferredDefinition":"Not otherwise specified.: Definition not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastrointestinal Tract","conceptCode":"C34082","definition":"The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DD3EA31-A386-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-05-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DD3EA31-A39F-25D9-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-05-22","modifiedBy":"ALEYR","dateModified":"2008-05-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2751294","version":"1","preferredName":"Systemic Scleroderma Involvement Type","preferredDefinition":"(sis-TEM-ik) Affecting the entire body.:A chronic disorder marked by hardening and thickening of the skin.  Scleroderma can be localized or it can affect the entire body (systemic).:To have a connection by participation or association or use; sharing in an activity or process.:Type; a subdivision of a particular kind of thing.","longName":"C13310:C26746:C25548:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic","conceptCode":"C13310","definition":"Affecting an entire system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Scleroderma","conceptCode":"C26746","definition":"A localized or systemic chronic and progressive autoimmune disorder characterized by thickening of the skin and the connective tissues. Localized scleroderma affects only the skin. Systemic scleroderma affects internal organs, including the heart, lungs, gastrointestinal tract, and kidneys.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC27EB3-51FB-54EB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-05-21","modifiedBy":"ONEDATA","dateModified":"2008-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0C70EA-4506-52CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-12","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-12","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"For the systemic sclerosis, w","type":"Preferred Question Text","description":"For the systemic sclerosis, what was the involved organ or clinical problem?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2748902","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.resultClassificationCode WHERE PerformedDiagnosis.value = \"systemic sclerosis\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D0E0AAB-42FE-3461-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-12","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-12","modifiedBy":"KUMMEROA","dateModified":"2016-09-12","changeDescription":". Alt name &#34;pre_ted_ss_df_cut_yn&#34; removed due to being used on CDE 2748907. AK 9/12/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}